Cargando…
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: The study was undertaken over a 9-month study period at a tertiary care and super specialty hospital situated in Jodhpur, Western Rajasthan, India, with the following objectives: 1. To determine the prevalence of Candidemia amon...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509851/ http://dx.doi.org/10.1093/mmy/myac072.P049 |
_version_ | 1784797319948926976 |
---|---|
author | Jain, Vidhi Nare, Tejashree Vishwakarma, Kirti Kundu, Aditya Radhkrishnan, Anjuna Tak, Vibhor Kumar, Deepak Sharma, Ankur Kothari, Nikhil |
author_facet | Jain, Vidhi Nare, Tejashree Vishwakarma, Kirti Kundu, Aditya Radhkrishnan, Anjuna Tak, Vibhor Kumar, Deepak Sharma, Ankur Kothari, Nikhil |
author_sort | Jain, Vidhi |
collection | PubMed |
description | POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: The study was undertaken over a 9-month study period at a tertiary care and super specialty hospital situated in Jodhpur, Western Rajasthan, India, with the following objectives: 1. To determine the prevalence of Candidemia among all blood culture positives. 2. Isolate profiling or speciation of Candida spp. 3. Antifungal susceptibility testing of the Candida isolates. METHODS: Automated blood culture bottles (BD BACTEC 960) that flagged positive were taken up for gram staining. Those bottles which showed gram-positive budding yeast with or without pseudohyphae were selected as the study isolates for candidemia. All such bottles were subcultures on Sabouraud's dextrose agar and incubates aerobically at 37(°)C for 2-5 days. Creamy, pasty, off-white colonies of Candida were further taken up for identification by germ tube testing, CHROM agar, and VITEK-MS. Antifungal susceptibility testing was performed for all isolates by VITEK 2 against fluconazole, caspofungin, voriconazole, micafungin, flucytosine, and amphotericin B. RESULTS: During the study period May 1, 2021-January 31, 2022, the microbiology laboratory received a total of 10 841 automated blood culture bottles, of which, overall, 1051 flagged positive. Budding yeasts were seen in 92 bottles. The prevalence of candidemia was found to be 1.49%. Budding yeasts made up 8.75% of all positive blood cultures. Conventional and automated identification methods showed the non-albicans Candida made up the majority (85.87%) of isolates. Candida tropicalis (43.47%) was the most common species overall, followed by C. parapsilosis (17.37%), C. albicans (14.13%), C. guilliermondi (5.43%), C. glabrata (5.43%), and C. auris (4.34%). Two isolates each of C. kruzei, C. utilis, C. rugosa, and Trichosporon spp. were also obtained. The antifungal susceptibility testing results for the commonest species C. tropicalis showed susceptibility of 90% against caspofungin and micafungin, 82% against fluconazole and voriconazole, 45% for flucytosine, and 47.5% against amphotericin B. C. albicans showed 100% susceptibility to fluconazole, and caspofungin, while C. parapsilosis showed a lower susceptibility percentage against all drugs in the panel. The two strains of C. auris were solely susceptible to caspofungin. Demography of the patients showed a male preponderance (M:F ratio was 2:1). The mean age of patients was 44 years. CONCLUSION: The prevalence of candidemia in Jodhpur, Western India was found to be 1.45%, a figure much less than that reported from most other tertiary care centers of the country. The commonest isolate was C. tropicalis (43.47%), same as that reported from most Indian studies. Our isolates were largely (>90%) susceptible to the drug of choice caspofungin, including the multidrug-resistant C. auris strains. The study findings reflect a low prevalence of candidemia, indicating adequate antibiotic and antifungal stewardship practices at Jodhpur. |
format | Online Article Text |
id | pubmed-9509851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95098512022-09-26 P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India Jain, Vidhi Nare, Tejashree Vishwakarma, Kirti Kundu, Aditya Radhkrishnan, Anjuna Tak, Vibhor Kumar, Deepak Sharma, Ankur Kothari, Nikhil Med Mycol Oral Presentations POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: The study was undertaken over a 9-month study period at a tertiary care and super specialty hospital situated in Jodhpur, Western Rajasthan, India, with the following objectives: 1. To determine the prevalence of Candidemia among all blood culture positives. 2. Isolate profiling or speciation of Candida spp. 3. Antifungal susceptibility testing of the Candida isolates. METHODS: Automated blood culture bottles (BD BACTEC 960) that flagged positive were taken up for gram staining. Those bottles which showed gram-positive budding yeast with or without pseudohyphae were selected as the study isolates for candidemia. All such bottles were subcultures on Sabouraud's dextrose agar and incubates aerobically at 37(°)C for 2-5 days. Creamy, pasty, off-white colonies of Candida were further taken up for identification by germ tube testing, CHROM agar, and VITEK-MS. Antifungal susceptibility testing was performed for all isolates by VITEK 2 against fluconazole, caspofungin, voriconazole, micafungin, flucytosine, and amphotericin B. RESULTS: During the study period May 1, 2021-January 31, 2022, the microbiology laboratory received a total of 10 841 automated blood culture bottles, of which, overall, 1051 flagged positive. Budding yeasts were seen in 92 bottles. The prevalence of candidemia was found to be 1.49%. Budding yeasts made up 8.75% of all positive blood cultures. Conventional and automated identification methods showed the non-albicans Candida made up the majority (85.87%) of isolates. Candida tropicalis (43.47%) was the most common species overall, followed by C. parapsilosis (17.37%), C. albicans (14.13%), C. guilliermondi (5.43%), C. glabrata (5.43%), and C. auris (4.34%). Two isolates each of C. kruzei, C. utilis, C. rugosa, and Trichosporon spp. were also obtained. The antifungal susceptibility testing results for the commonest species C. tropicalis showed susceptibility of 90% against caspofungin and micafungin, 82% against fluconazole and voriconazole, 45% for flucytosine, and 47.5% against amphotericin B. C. albicans showed 100% susceptibility to fluconazole, and caspofungin, while C. parapsilosis showed a lower susceptibility percentage against all drugs in the panel. The two strains of C. auris were solely susceptible to caspofungin. Demography of the patients showed a male preponderance (M:F ratio was 2:1). The mean age of patients was 44 years. CONCLUSION: The prevalence of candidemia in Jodhpur, Western India was found to be 1.45%, a figure much less than that reported from most other tertiary care centers of the country. The commonest isolate was C. tropicalis (43.47%), same as that reported from most Indian studies. Our isolates were largely (>90%) susceptible to the drug of choice caspofungin, including the multidrug-resistant C. auris strains. The study findings reflect a low prevalence of candidemia, indicating adequate antibiotic and antifungal stewardship practices at Jodhpur. Oxford University Press 2022-09-20 /pmc/articles/PMC9509851/ http://dx.doi.org/10.1093/mmy/myac072.P049 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Oral Presentations Jain, Vidhi Nare, Tejashree Vishwakarma, Kirti Kundu, Aditya Radhkrishnan, Anjuna Tak, Vibhor Kumar, Deepak Sharma, Ankur Kothari, Nikhil P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India |
title | P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India |
title_full | P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India |
title_fullStr | P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India |
title_full_unstemmed | P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India |
title_short | P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India |
title_sort | p049 candidemia: isolate profiling and antifungal susceptibility testing experience from jodhpur, western india |
topic | Oral Presentations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509851/ http://dx.doi.org/10.1093/mmy/myac072.P049 |
work_keys_str_mv | AT jainvidhi p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT naretejashree p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT vishwakarmakirti p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT kunduaditya p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT radhkrishnananjuna p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT takvibhor p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT kumardeepak p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT sharmaankur p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia AT kotharinikhil p049candidemiaisolateprofilingandantifungalsusceptibilitytestingexperiencefromjodhpurwesternindia |